Correlation Between Beta Drugs and Le Travenues
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Le Travenues at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Le Travenues into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Le Travenues Technology, you can compare the effects of market volatilities on Beta Drugs and Le Travenues and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Le Travenues. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Le Travenues.
Diversification Opportunities for Beta Drugs and Le Travenues
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Beta and IXIGO is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Le Travenues Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Le Travenues Technology and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Le Travenues. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Le Travenues Technology has no effect on the direction of Beta Drugs i.e., Beta Drugs and Le Travenues go up and down completely randomly.
Pair Corralation between Beta Drugs and Le Travenues
Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.16 times more return on investment than Le Travenues. However, Beta Drugs is 1.16 times more volatile than Le Travenues Technology. It trades about 0.24 of its potential returns per unit of risk. Le Travenues Technology is currently generating about -0.07 per unit of risk. If you would invest 194,260 in Beta Drugs on August 30, 2024 and sell it today you would earn a total of 30,400 from holding Beta Drugs or generate 15.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Beta Drugs vs. Le Travenues Technology
Performance |
| Timeline |
| Beta Drugs |
| Le Travenues Technology |
Beta Drugs and Le Travenues Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beta Drugs and Le Travenues
The main advantage of trading using opposite Beta Drugs and Le Travenues positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Le Travenues can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Le Travenues will offset losses from the drop in Le Travenues' long position.| Beta Drugs vs. Reliance Industries Limited | Beta Drugs vs. Tata Consultancy Services | Beta Drugs vs. HDFC Bank Limited | Beta Drugs vs. Bharti Airtel Limited |
| Le Travenues vs. Easy Trip Planners | Le Travenues vs. Yatra Online Limited | Le Travenues vs. ABM International Limited | Le Travenues vs. Consolidated Construction Consortium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |